SBC Medical Group Holdings Incorporated Finance Lease, Right-of-Use Asset, Amortization
SBC Medical Group Holdings Incorporated (SBC) reported Finance Lease, Right-of-Use Asset, Amortization of $28.50 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $28.50K, a 7.69% decline year-over-year.
- SBC Medical Group Holdings Incorporated finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $31.85K, a 216.94% increase year-over-year.
- SBC Medical Group Holdings Incorporated finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $31.32K.
- SBC Medical Group Holdings Incorporated finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $31.46K.
- SBC Medical Group Holdings Incorporated finance lease, right-of-use asset, amortization for fiscal 2025 was $103.70K.
- SBC Medical Group Holdings Incorporated finance lease, right-of-use asset, amortization for fiscal 2024 was $0.00.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.50K 10-Q · filed 2026-08-13 | $60.35K 10-Q · filed 2026-08-13 | $91.67K derived: sum of 3 quarters · filed 2026-08-13 | $123.13K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $31.85K 10-Q · filed 2026-05-14 | $63.17K derived: sum of 2 quarters · filed 2026-05-14 | $94.63K derived: sum of 3 quarters · filed 2026-05-14 | $125.50K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $31.32K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $62.78K derived: sum of 2 quarters · filed 2026-03-27 | $93.65K derived: sum of 3 quarters · filed 2026-08-13 | $103.70K 10-K · filed 2026-03-27 |
| 2025-09-30 | $31.46K 10-Q · filed 2025-11-14 | $62.33K derived: sum of 2 quarters · filed 2026-08-13 | $72.38K 10-Q · filed 2025-11-14 | $72.38K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $30.87K 10-Q · filed 2026-08-13 | $40.92K 10-Q · filed 2026-08-13 | $40.92K derived: sum of 3 quarters · filed 2026-08-13 | $40.92K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $10.05K 10-Q · filed 2026-05-14 | $10.05K derived: sum of 2 quarters · filed 2026-05-14 | $10.05K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |